Combination Therapy with Low‐Dose Etretinate and Eicosapentaenoic Acid for Psoriasis Vulgaris

Publisher: John Wiley & Sons Inc

E-ISSN: 1346-8138|25|11|703-705

ISSN: 0385-2407

Source: THE JOURNAL OF DERMATOLOGY, Vol.25, Iss.11, 1998-11, pp. : 703-705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

AbstractA randomized open study was undertaken to compare the therapeutic effects between low‐dose etretinate alone and low‐dose etretinate combined with eicosapentaenoic acid in 40 patients with chronic, stable psoriasis vulgaris. Better and more rapid improvement was obtained with the combination therapy for 12 weeks than with low‐dose etretinate monotherapy. Eicosapentaenoic acid was safe, and adverse reactions due to low‐dose etretinate were mild or tolerable. The combination regimen, therefore, has a satisfactory effect on psoriasis without marked adverse reactions.

Related content